William V Kastrinakis, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anastomosis, Surgical | 2 | 2024 | 991 | 0.360 |
Why?
|
| Anastomotic Leak | 1 | 2024 | 170 | 0.210 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2024 | 516 | 0.180 |
Why?
|
| Inappropriate Prescribing | 1 | 2019 | 212 | 0.140 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 937 | 0.110 |
Why?
|
| Genes, p53 | 1 | 1995 | 714 | 0.100 |
Why?
|
| Colectomy | 2 | 2024 | 696 | 0.100 |
Why?
|
| Genes, ras | 1 | 1995 | 663 | 0.100 |
Why?
|
| Point Mutation | 1 | 1995 | 1596 | 0.090 |
Why?
|
| Liver Neoplasms | 2 | 1995 | 4363 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1765 | 0.080 |
Why?
|
| Caregivers | 1 | 2021 | 2302 | 0.080 |
Why?
|
| Colorectal Neoplasms | 3 | 1995 | 6975 | 0.060 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 2188 | 0.060 |
Why?
|
| Forms and Records Control | 1 | 2005 | 158 | 0.060 |
Why?
|
| Codon | 2 | 1995 | 599 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3837 | 0.050 |
Why?
|
| Pancreatic Ducts | 1 | 2024 | 330 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7454 | 0.050 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2005 | 388 | 0.050 |
Why?
|
| Rectum | 1 | 2024 | 900 | 0.040 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2005 | 583 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2009 | 2235 | 0.040 |
Why?
|
| Exons | 2 | 1995 | 2394 | 0.040 |
Why?
|
| Colonic Neoplasms | 2 | 2024 | 2541 | 0.040 |
Why?
|
| Drug Utilization Review | 1 | 2019 | 248 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3706 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 1995 | 6395 | 0.030 |
Why?
|
| Colon | 1 | 2024 | 1801 | 0.030 |
Why?
|
| Base Sequence | 3 | 1995 | 12422 | 0.030 |
Why?
|
| Rectal Neoplasms | 1 | 2024 | 1183 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 6082 | 0.030 |
Why?
|
| Tunicamycin | 1 | 1995 | 109 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 1995 | 17623 | 0.030 |
Why?
|
| Drug Resistance, Multiple | 1 | 1995 | 255 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 2862 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 1995 | 6124 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2019 | 1141 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 997 | 0.030 |
Why?
|
| Weight Loss | 1 | 2005 | 2721 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 22371 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1995 | 1062 | 0.020 |
Why?
|
| DNA Primers | 1 | 1995 | 2828 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 1668 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2021 | 3140 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1744 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2019 | 2697 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2019 | 3583 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 1995 | 985 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2021 | 2517 | 0.020 |
Why?
|
| Hospitals | 1 | 2021 | 3886 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1995 | 1966 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15833 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 5442 | 0.020 |
Why?
|
| Unnecessary Procedures | 1 | 2009 | 412 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2021 | 4310 | 0.020 |
Why?
|
| MEDLINE | 1 | 2005 | 119 | 0.010 |
Why?
|
| Cell Line | 2 | 1995 | 15602 | 0.010 |
Why?
|
| Catheterization, Central Venous | 1 | 2009 | 537 | 0.010 |
Why?
|
| Humans | 11 | 2024 | 768171 | 0.010 |
Why?
|
| Device Removal | 1 | 2009 | 643 | 0.010 |
Why?
|
| Carotid Artery Diseases | 1 | 1991 | 879 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1995 | 4249 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13422 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1995 | 2195 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2009 | 1309 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1995 | 5804 | 0.010 |
Why?
|
| Middle Aged | 3 | 2024 | 223487 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2024 | 81760 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 2176 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 1667 | 0.010 |
Why?
|
| Risk Factors | 1 | 2024 | 74944 | 0.010 |
Why?
|
| United States | 2 | 2019 | 73039 | 0.010 |
Why?
|
| Male | 3 | 2024 | 364731 | 0.010 |
Why?
|
| Aged | 2 | 2024 | 171502 | 0.010 |
Why?
|
| Female | 3 | 2024 | 397187 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 13290 | 0.010 |
Why?
|
| Prognosis | 1 | 1995 | 30009 | 0.010 |
Why?
|
| Mutation | 2 | 1995 | 30237 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 1995 | 362 | 0.010 |
Why?
|
| Glycosylation | 1 | 1995 | 1100 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1995 | 671 | 0.010 |
Why?
|
| Cadherins | 1 | 1995 | 905 | 0.010 |
Why?
|
| Life Tables | 1 | 1991 | 367 | 0.010 |
Why?
|
| Endarterectomy | 1 | 1991 | 196 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1995 | 5028 | 0.000 |
Why?
|
| Constriction, Pathologic | 1 | 1991 | 1104 | 0.000 |
Why?
|
| Carotid Arteries | 1 | 1991 | 942 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1995 | 3655 | 0.000 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1995 | 2956 | 0.000 |
Why?
|
| Adult | 1 | 2019 | 223646 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1995 | 5902 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1995 | 8316 | 0.000 |
Why?
|
| Cerebrovascular Disorders | 1 | 1991 | 1485 | 0.000 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 4528 | 0.000 |
Why?
|
| Gene Expression | 1 | 1995 | 7601 | 0.000 |
Why?
|
| Obesity | 1 | 2005 | 13091 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1995 | 11095 | 0.000 |
Why?
|
| Reoperation | 1 | 1991 | 4329 | 0.000 |
Why?
|
| Disease Progression | 1 | 1995 | 13668 | 0.000 |
Why?
|
| Recurrence | 1 | 1991 | 8509 | 0.000 |
Why?
|
| Phenotype | 1 | 1995 | 16726 | 0.000 |
Why?
|
| Sex Factors | 1 | 1991 | 10632 | 0.000 |
Why?
|
| Incidence | 1 | 1991 | 21538 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1991 | 39354 | 0.000 |
Why?
|
| Time Factors | 1 | 1991 | 40220 | 0.000 |
Why?
|